V260 Study: Concomitant Use of V260 and INFANRIX™ Hexa in Healthy Infants (V260-010)

Clinical trial NCT00258154 · COMPLETED

Trial details

NCT number: NCT00258154
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rotavirus Disease

Start date: 2006-02-01
Primary completion: 2006-11-01
Enrollment: 403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.